Sage Therapeutics (SAGE)
(Delayed Data from NSDQ)
$10.99 USD
+0.52 (4.97%)
Updated Jul 26, 2024 04:00 PM ET
After-Market: $10.97 -0.02 (-0.18%) 7:58 PM ET
3-Hold of 5 3
D Value B Growth D Momentum D VGM
Detailed Estimates
EPS Estimates
Earnings Date | *AMC7/31/24 |
---|---|
Current Quarter | -1.66 |
EPS Last Quarter | -1.80 |
Last EPS Surprise | -10.43% |
ABR | 2.86 |
Earnings ESP
|
-4.41% |
---|---|
Current Year | -6.56 |
Next Year | -5.02 |
EPS (TTM) | -7.84 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 8.48M | 10.38M | 39.85M | 154.02M |
# of Estimates | 10 | 10 | 11 | 11 |
High Estimate | 11.05M | 15.20M | 56.79M | 584.56M |
Low Estimate | 6.79M | 7.48M | 32.00M | 52.38M |
Year ago Sales | 2.47M | 2.72M | 86.46M | 39.85M |
Year over Year Growth Est. | 243.36% | 281.51% | -53.91% | 286.48% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -1.66 | -1.61 | -6.56 | -5.02 |
# of Estimates | 12 | 10 | 13 | 13 |
Most Recent Consensus | -1.58 | -1.85 | -7.32 | -5.50 |
High Estimate | -1.42 | -1.32 | -5.66 | 3.59 |
Low Estimate | -1.82 | -1.85 | -7.33 | -7.54 |
Year ago EPS | -2.68 | -2.81 | -9.05 | -6.56 |
Year over Year Growth Est. | 38.06% | 42.70% | 27.51% | 23.49% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 1 | 1 | 1 |
Up Last 30 Days | 1 | 1 | 1 | 1 |
Up Last 60 Days | 2 | 2 | 2 | 1 |
Down Last 7 Days | 1 | 1 | 2 | 1 |
Down Last 30 Days | 2 | 2 | 4 | 3 |
Down Last 60 Days | 2 | 1 | 3 | 4 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -1.66 | -1.61 | -6.56 | -5.02 |
7 Days Ago | -1.66 | -1.61 | -6.54 | -5.01 |
30 Days Ago | -1.66 | -1.60 | -6.48 | -4.93 |
60 Days Ago | -1.69 | -1.63 | -6.53 | -5.01 |
90 Days Ago | -1.70 | -1.65 | -6.60 | -4.97 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -1.74 | -1.74 | -6.88 | -6.46 |
Zacks Consensus Estimate | -1.66 | -1.61 | -6.56 | -5.02 |
Earnings ESP | -4.41% | -8.01% | -4.78% | -28.55% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -1.80 | -0.55 | -2.81 | -2.68 | NA |
Estimate | -1.63 | -1.18 | -2.64 | -2.53 | NA |
Difference | -0.17 | 0.63 | -0.17 | -0.15 | 0.04 |
Surprise | -10.43% | 53.39% | -6.44% | -5.93% | 7.65% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more